DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Yao JC, Fazio N, Singh S. et al.
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.
Lancet 2016;
387: 968-977
doi:10.1016/S0140-6736(15)00817-X
We do not assume any responsibility for the contents of the web pages of other providers.